Clin2
NCT06353334Possibly a fitRecruiting

Butylphthalide for brain recovery after cardiac arrest

ButylphthalideCardiac ArrestNeuroprotective Drugs

Part of Heart & circulation clinical trials.

This trial tests if butylphthalide can improve brain function in people who have been resuscitated after a cardiac arrest. It may help reduce brain damage and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You were unconscious (GCS score of 8 or lower) when you arrived at the hospital.
  • Your heart was restarted and kept beating for at least 30 minutes.
  • You or your legal guardian have signed a consent form to participate.
  • You do not have pre-existing brain or bleeding problems, severe organ failure, or other conditions listed in the exclusion criteria.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06572085Recruiting· Phase 4
Butylphthalide for brain protection after cardiac arrest

This trial tests a medicine called butylphthalide (NBP) to see if it helps protect the brain after a cardiac arrest. It is for adults who remained unconscious after their heart was restarted.

Beijing, Beijing Municipality
NCT06660238Not yet recruiting
Brain PET-CT after cardiac arrest

This trial uses a special brain scan (PET-CT) to see how the brain is affected after a cardiac arrest. It may help doctors better understand damage and recovery in people who remain unconscious.

Beijing, Beijing Municipality
NCT06992843Recruiting
Protecting the brain after cardiac arrest coma

This trial tests a set of treatments designed to protect the brain in people who remain unconscious after their heart restarts following a cardiac arrest. It may help improve recovery by preventing further brain injury.

Changsha, Hunan
NCT06455514Recruiting· Phase 1
Magnesium to protect the brain after cardiac arrest

This study tests if giving magnesium soon after a cardiac arrest can protect the brain and improve recovery. It is for adults who have been brought back to life after a heart stoppage.

New York, New York
NCT06503016Recruiting· Phase 3
Phosphocreatine for medical emergency team patients

This study tests if a medicine called phosphocreatine helps people in the hospital who have a serious heart or lung emergency. It aims to see if the medicine can improve recovery and prevent further complications.

Milan
NCT06704685Not yet recruiting· Phase 3
Butylphthalide for heart attack patients after stent placement

This trial tests if adding butylphthalide to standard care can reduce heart muscle damage in people having a major heart attack (STEMI) who are getting a stent. It aims to improve recovery and outcomes.

Hear when a new Cardiac Arrest trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.